This document discusses various antifungal agents including their classification, mechanisms of action, and uses. It covers several classes of antifungals such as polyenes (e.g. amphotericin B), azoles (e.g. fluconazole, itraconazole), and echinocandins (e.g. caspofungin). It also discusses the antifungal spectra, pharmacokinetics, advantages/disadvantages, and adverse effects of different antifungal drugs. The document provides a comprehensive overview of the major antifungal agents used in clinical practice.
This ppt deals with the sulfonamide group of drugs with classification, mechanism, spectrum, resistance, uses and adverse effects discussed in detail. It also discusses in detail about Cotrimoxazole
Definition
History
Chemistry
Properties
Classification & its Generation
Pharmacokinetics
Mechanism of action
Indication
Contraindication
Therapeutic use
Adverse effect
Resistance
Comparison with penicillin
Market preparation
Tetracyclines slide contains full information about uses, adverse effect, marketed preparation, precaution, route of drug administration, antimicrobial spectrum, mechanism of action, pharmacokineticks and pharmacodynamics of tetracyclines. This slide is very helpful for pharmacy and pharmacology student for the study about tetracyclines.
Sulfonamide (also called sulphonamide, sulfa drugs or sulpha drugs) is the basis of several groups of drugs. The original antibacterial sulfonamides are synthetic antimicrobial agents that contain the sulfonamide group.
Antiprotozoal agents is a class of pharmaceuticals used in treatment of protozoan infection. Protozoans have little in common with each other and so agents effective against one pathogen may not be effective against another
This ppt deals with the sulfonamide group of drugs with classification, mechanism, spectrum, resistance, uses and adverse effects discussed in detail. It also discusses in detail about Cotrimoxazole
Definition
History
Chemistry
Properties
Classification & its Generation
Pharmacokinetics
Mechanism of action
Indication
Contraindication
Therapeutic use
Adverse effect
Resistance
Comparison with penicillin
Market preparation
Tetracyclines slide contains full information about uses, adverse effect, marketed preparation, precaution, route of drug administration, antimicrobial spectrum, mechanism of action, pharmacokineticks and pharmacodynamics of tetracyclines. This slide is very helpful for pharmacy and pharmacology student for the study about tetracyclines.
Sulfonamide (also called sulphonamide, sulfa drugs or sulpha drugs) is the basis of several groups of drugs. The original antibacterial sulfonamides are synthetic antimicrobial agents that contain the sulfonamide group.
Antiprotozoal agents is a class of pharmaceuticals used in treatment of protozoan infection. Protozoans have little in common with each other and so agents effective against one pathogen may not be effective against another
Fungal infections are more common in men and in women, especially in younger people due to their clothing style. they must be stopped at the budding stage, if not it might spread to multiple areas of body.
Immunosupressants and Immunostimulants their pharmacology, uses etc. Basics of immunology, innate immune response, acquired immune response, role of complement in innate immune response. Major histocompatibility complex, antibody structure. classification of immunosupressants, their mechanism of action, uses and adverse effects.
Pharmacology of antimalarial drugs with treatment of malaria. mechanism of action, uses, adverse effects of antimalarial drugs like chloroquine, quinine, artemisinin compounds.
Antileprosy drugs have been described with their pharmacology also this topic covers Multidrug treatment for leprosy including paucibacillary and multibacillary leprosy and lepra reactions
Pharmacology of cephalosporins, monobactums and carbapenums including their mechanism of action, indications, adverse effects.
The various generations of cephalosporins and their spectrum of action
Pharmacology of Penicllins (Beta lactam antibiotics), description of their mechanism of action, mechanism of resistance, classification, indications and adverse effects
Drugs for treatment of Diabetes MellitusNaser Tadvi
These slides contain the brief description of Insulin and the other oral drugs indicated in the treatment of Diabetes Mellitus. Their mechanism of action, effects, uses, Adverse effects etc.
Introduction to Autonomic Nervous systemNaser Tadvi
Lecture intends to give a brief overview of autonomic nervous system.
it includes the anatomical distribution of ANS, Neurohumoral transmission, co-transmission, receptors for ANS and synthesis of the neurotransmitters, Acetylcholine and Catecholamines
Lecture covers the pharmacology of anticholinergic drugs. Includes classification, therapeutic uses, adverse effects of anticholinergics. Atropine has been described as prototype drug.
Lecture includes definition of bioassay, Types of Assay and Bioassay , Indications, principles, advantages of bioassay. Example of a Bioassay with calculations. This lecture will be of help for postgraduate pharmacology students as well as undergraduates
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
11. Mechanism of action
Amphotericin B
Binds ergosterol in fungal cell membrane
Form pores in cell membrane
Cell contents leak out
Cell death
12. Antifungal spectrum
- Aspergillus
- Blastomyces dermatitidis
Broadest spectrum
- Candida albicans of action
- Cryptococcus neoformans
- Coccidioides immitis Fungicidal at high &
static at low conc.
- Histoplasma capsulatum
- Mucor spp.
Also active against Leshmania
13. Mechanism of resistance
• Resistance:
– Replacement of ergosterol by other sterols in
fungal plasma membrane.
– Resistance is not a problem clinically.
14. Pharmacokinetics
• Poorly absorbed orally
• Insoluble in water so colloidal
suspension prepared with sodium
deoxycholate(1:1 complex)
• 90% bound to plasma proteins
• Metabolized in liver slowly
excreted in urine
• t ½ = 15 days
15. Administration & dose
• Systemic mycosis: IV
– Available as 50mg vial – suspended in 10 ml water
and then diluted with 500 ml glucose
– 0.5mg/kg to 1 mg/kg
– Total dose- 3-4 gm over 2-3 months
• Intestinal Monoliasis: 50-100 mg QID Orally
• Vaginitis: topical
• Otomycosis: 3 % drops
• Intrathecal: 0.5 mg BD in fungal meningitis
16. Uses
• Useful drug in nearly all life threatening mycotic
infections
• Treatment of invasive aspergillosis
• Rapidly progressive Blastomycosis &
Coccidiomycosis
• Cryptococcus neoformans
• Mucormycosis.
• Disseminated rapidly progressing Histoplasmosis
• Reserve drugs for resistant kala azar
• Topical uses:
17. • Adverse events:
– Acute reaction:
– Chills, fever, headache, pain all over,
nausea, vomiting, dyspnoea lasting 2-5 hrs
because of release of IL & TNF
– can be treated with hydrocortisone
0.6mg/kg
– Long term toxicity:
– Nephrotoxicity: Azotemia,
Hypokalemia, acidosis, ↓ GFR
– anemia
– CNS toxicity : intrathecal administration,
headache, vomiting, nerve palsies
– Hepatotoxicity rarely
18. Disadvantages of AMB
SIDE AmphotericinAMB toxic
EFFECTS OF B is
Nephrotoxicity
Acute infusion related reactions
Hypopotassemia, anemia, hepatic
dysfunction..
19. Lıpıd formulations of amphotericin B
Amphotericin B Lipid Complex
(ABLC; Abelcet®)
Amphotericin B Colloidal Dispersion
(ABCD; Amphocil® or Amphotec®)
Liposomal Amphotericin B
(L-AMB; Ambisome®)
20. ABLC
AMB Lipid complex (ABLC):
35% AMB incorporated in
ribbon like particles of
dimyristoyl phospholipids
Ribbon-like particles
Carrier lipids: DMPC, DMPG
J Liposome Res 1993; 3:
451
21. ABCD
AMB colloidal
dispersion (ABCD):
Disc shaped
particles
containing 50%
each of AMB &
cholesteryl ester in
Disk-shaped
aqueos dispersion particles
Carrier lipid: Cholesteryl sulfate
J Pharmaceutics 1991; 75:
45
22. The ‘LIPOSOME’..
•Liposomal AMB (Small
unilamellar vesicles) :
10% AMB
incorporated in
SUV made up of
lecithin
Lipid formulations:
20-50 times more
expensive than
AmB-deoxycholate
Hospital Practice 1992; 30: 53
23. Major advantages of lipid AMB
formulations
Macrophage
Milder acute reaction
Liposome Lysosome
Can be used in intolerance
Fusion
to conventional preparations Liposome
degradation
Lower nephrotoxicity & Endocytosis
anemia
Deliver AMB to RES of liver Endocytic
vesicle
speen so useful in leshmania
Release in blood Release from
& immunocompromised compartment macrophage
Can be used in higher doses Liposomes in the therapy of infectious
diseases and cancer 1989: 105
24. Nystatin
Obtained from S.Noursei
Similar to AMB in antifungal properties, high
systemic toxicity so used locally only
Poorly absorbed from mucus membrane
Available as ointment ,cream , powder, tablet
Uses:
5 lac U in intestinal moniliasis TDS
1 lac U in vaginitis
Prevention of oral candidiasis
Can be used in oral, cutaneous, conjunctival candidiasis
Adverse events:
Gastointestinal disturbances with oral tablets
25. Hamycin:
S. Pimprina
Hindustan antibiotics pimpri
More water soluble, fraction absorbed orally but
unreliable in systemic infections
Topical use in thrush, cutaneous candidiasis,
trichomonas & monilial vaginitis, otomycosis by
aspergillus
Natamycin:
Similar to nystatin, broad spectrum
Used topically 1%, 3% ointment
Fusarium solani keratitis, trichomonas & monilial
vaginitis
26. Griseofulvin
• One of early antibiotics from penicillium
griseofulvum
• Fungistatic, systemic drug for superficial
fungal infections
• Active against most dermatophytes
• Dermatophytes concentrate it actively hence
selective toxicity
• Resistance: loss of concentrating ability
27. • Mechanism of action:
– Griseofulvin interacts with
polymerized microtubules and
disrupts the mitotic spindles thus
arresting fungal mitosis
• Pharmacokinetics:
– Oral administration, irregular
absorption, increased by fatty food
and microfine particles
– Gets conc in keratinized tissue
– Metabolized in liver, excreted in
urine,t1/2=24 hrs
30. • Uses:
– Systemically only for dermatophytosis, ineffective
topically
• Systemic azoles more effective and preferred
• Duration of treatment depends on site,
thickness of keratin and turnover of keratin.
• Treatment must be continued till infected
tissue is completely replaced by normal
skin,hair, nail.
• Dose: 125-250 mg QID
31. Duration of treatment
• Body skin = 3 weeks
• Palm, soles = 4- 6 weeks
• Finger nails = 4- 6months
• Toe nails = 8 – 12 months
• Griseofulvin should be reserved for nail hair or
larger body surface involvement
• Interactions:
– Warfarin , OCP
– Phenobarbitone, Disulfiram like reaction
32. 5 flucytosine
– Prodrug, pyrimidine analog, antimetabolite
– Converted to 5 FU
– Human cells cant convert it to 5FU
– Adverse events:
• Bone marrow toxicity , GIT , Alopecia, skin rashes,
itching , rarely hepatitis
– Uses: in combination with AMB in cryptococcal
meningitis
– Narrow spectrum of action
33.
34. Advantages of combination:
–Entry of 5 FC
–Reduced toxicity
–Rapid culture conversion
–Reduced duration of therapy
–Decreased resistance
35. • Differences between AMB & 5 FC
• AMB = Active drug, broad spectrum, antibiotic,
fungicidal
• Not absorbed, high protein binding, no BBB,
metabolized in liver, highly efficacious,
IV,Intrathecal,topical
36. • Azoles:
– Synthetic antifungals
– Broad spectrum
– Fungistatic or fungicidal depending on conc of
drug
– Most commonly used
– Classified as imidazoles & triazoles
• Imidazoles: Two nitrogen in structure
– Topical: econazole, miconazole, clotrimazole
– Systemic : ketoconazole
– Newer : butaconazole, oxiconazole, sulconazole
37. • Triazoles : Three nitrogen in structure
– Fluconazole, itraconazole, voriconazole
– Terconazole: Topical for superficial infections
• Both these groups are
– Structurally related compounds
– Have same mechanism of action
– Have similar antifungal spectrum
39. Miconazole & clotrimazole
• Topical use:
– Miconazole 2 % and clotrimazole 1 % applied BD for
2 weeks in pityriasis versicolor, 4 weeks in cruris,
capitis and corporis
• Uses:
– Dermatophyte infections
– Candida: oral pharyngeal, vaginal, cutaneous
• Adverse events:
– Local irritation , itching or burning
– Miconazole shows higher incidence of vaginal irritation &
pelvic cramps
40. Ketoconazole
– First orally effective broad spectrum antifungal
– Effective against
• Dermatophytosis, Deep mycosis , Candidiasis
41. Pharmacokinetics
• Effective orally
• acidic environment
favours absorption
• High protein binding
• Readily distributed, not to
BBB
• Metabolized in liver,
excreted in bile
• t1/2 = 8- 10 hrs
• Dose : 200 mg OD or BD
44. Uses
• Dermatophytosis: conc in stratum corneum
• Monilial vaginitis : 5-7 days
• Systemic mycosis: blastomycosis,
histoplasmosis, coccidiodomycosis
– Less efficacy than AMB & slower response
– ↓Efficacy in immunocompromized and meningitis
– Lower toxicity than AMB higher than triazoles
• High dose used in cushings syndrome
• Topical: T.pedis, cruris, corporis, versicolor
45. Fluconazole
• Newer water soluble triazole
– Oral, IV as well as topical
– Broad spectrum antifungal activity
• Candida, cryptococcosis, coccidiodomycosis
• Dermatophytosis
• Blastomycosis
• Histoplasmosis
• Sporotrichosis
• Not effective against aspergillosis & mucormycosis
46. Pharmacokinetics
94% oral bioavailability
Not affected by food or gastric pH
Primarily excreted unchanged in urine t1/2 =
25 -30 hrs
Poor protein binding
Widely distributed crosses BBB
47. Adverse events
GIT upset
Headache, alopecia, skin rashes, hepatic necrosis
Teratogenic effect
CYP450 Enzyme inhibiting property less Interactions:
Effects hepatic drug metabolism to lesser extent than
Ketoconazole
H2 blockers & PPI do not effect its absorption
No anti androgenic & other endocrine effects
48. Uses
Candida:
150 mg oral dose can cure vaginal candidiasis with
few relapse
Oral candidiasis- 2 weeks treatment required
Tinea infections & cutaneous candidiasis: 150 mg
weekly for 4 weeks, tinea unguim : 12 months
systemic fungal infections: Disseminated
candidiasis, cryptococcal, coccidiodal meningitis
200-400 mg / day 4- 12 weeks or longer
Meningitis: preferred drug
Eye drops for fungal keratitis
49. Itraconazole
Broadest spectrum of activity also against
aspergillus
Fungistatic but effective in
immunocompromised
Does not inhibit steroid hormone synthesis
and no serious hepatoxicity
50. Pharmacokinetics
50-60% bioavailability, absorption is variable,
enhanced by food & gastric acidity
High protein binding 99 %
Well distributed accumulates in vaginal
mucosa, skin, nails but CNS penetration is poor
Metabolized in liver CYP3A4 excreted in feces
t1/2= 30- 64hr
51. Uses
DOC for paracoccidomycosis & chromoblastomycosis
DOC for histoplasmosis & blastomycosis
Esophageal, oropharyngeal vaginal candidiasis
Not superior to fluconazole : 200 mg OD X 3 days
Dermatophytosis: less effective than fluconazole
100- 200 mg OD X 15 days
Onychomycosis : 200 mg / day for 3 months
Intermittent pulse regime 200 BD once a week / month for 3
months equally effective
Aspergillosis: 200 mg OD/ BD with meals for 3 months
or more
52. Adverse events
• GI Intolerance
• Dizziness, pruritis , headache , hypokalemia
• Increase plasma transaminase
• Rarely hepatotoxicity
• Drug interactions:
– Oral absorption ↓by antacids, H2 blockers
– Rifampicin, phenytoin induce metabolism
– Inhibits CYP3A4 drug interaction profile similar to
ketoconazole
53. Triazoles
Itraconazole Fluconazole
- Varied absorption. - Completely absorbed and
Metabolized by cyt P450 better tolerated, Renal
excretion
- less endocrine effects but - Less endocrine effects
occur at high doses
- Penetrates well into CSF
- Less penetration in CSF
- Many drug interactions - Drug Interactions
(due to inhibition of CYT
P450/ 3A4)
54. Voriconazole
II generation triazole
High oral bioavailability, low protein binding
Good CSF penetration
Metabolized by CYP2C19
Doesn’t require gastric acidity for absorption
T1/2= 6 hrs
Uses:
DOC for invasive aspergillosis
Most useful for esophageal candidiasis
First line for moulds like fusarium
Useful in resistant candida infections
55. Dose and Adverse effects
• Dose : 200 mg BD
• Adverse events:
– Transient visual changes like blurred vision ,
altered color perception & photophobia
– Rashes in 5 -6 %
– Elevated hepatic enzymes
– Prolongation of QT
56. Terbinafine
Orally & topically effective drug against
candida & dermatophytes
Fungicidal : shorter courses of therapy
required & low relapse rates
Mechanism of action:
Pharmacokinetics:
Well absorbed orally 75%
Highly keratophilic & lipophilic
High protein bound , poor BBB permeability
t1/2- 15 days
Negligible effect on CYP450
57. Adverse events and uses
Adverse events:
Nausea , vomiting , Diarrhoea
Taste disturbances
Rarely hepatic dysfunction
Topical: erythema , itching , dryness , urticaria,
rashes
Uses:
Dermatophytosis: topically/ orally 2- 6 weeks
Onychomycosis: first line drug 3- 12 months
Candidiasis: less effective 2- 4 weeks therapy may
be used as alternative 250 mg OD
58. Caspofungin acetate
Semisynthetic antifungal
MOA: Inhibits B (1,3) D glucan an essential
component of fungal cell wall
Uses: Treatment of invasive aspergillosis &
candidiasis (esophageal, intraperitoneal)
Dose: IV 70 mg slowly then 50 mg daily infusion
Adverse events:
Flushing rashes , nausea, vomiting, phlebitis
59. Topical agents used in dermatophytosis
Tolnaftate:
Tinea, cruris, corporis, 1- 3 weeks treatment
Not effective in hyperkeratinized lesions
Salicylic acid aids its effect by keratolysis
Ciclopirox olamine:
Tinea infections, pitryasis versicolor ,dermal
candidiasis, vaginal candidiasis
Penetrates superficial layers
Acts by inhibiting membrane uptake of precursors
of macromolecules needed for fungal growth
60. Topical agents used in dermatophytosis
• Undecyclenic acid: 5% (Tineafax)
– Generally combined with zinc (20%)
– Requires prolonged treatment has high relapse
rate
– Weaker antifungal action used in tinea cruris and
nappy rash
• Sodium thiosulfate: (Karpin lotion)
– Reducing agent known as hypo
– Effective in pitryasis versicolor only 20 % solution
for 3-4 weeks
61. Topical agents used in dermatophytosis
• Benzoic acid:
– Used in combination with salicylic acid
– Whitfields ointment: ( benzoic acid 6% + salicyclic
acid 3 %)
– Salicyclic acid due to its keratolytic action helps to
remove infected tissue & promotes penetration of
benzoic acid in fungal infected lesion
– Adverse events: irritation & burning sensation
(Ring cutter ointment)
64. Spectrum of action
AMB 5FC KTZ FLU ITR
Aspergillus -- -- -- Y
Blastomycosis -- Y Y Y
cryptococcus Y -- Y Y
Coccidiodo -- Y Y Y
candida Y Y Y Y
Histoplasma -- Y Y Y
mucor -- -- -- --
Sporotrichosis -- -- Y Y
chromoblast dermatophyte Fusarium
65. Spectrum of action
• Nystatin: Candidiasis only
• Griseofulvin: Dermatophytosis only
• Terbinafine : Dermatophytosis & candidiasis
• Caspofungin: Aspergillosis & candidiasis
66. Important characteristics
• Broad spectrum: AMB, KTZ, FLU, ITR
• Resistance: 5 FC
• Nephrotoxic/ Anemia: AMB
• Leucopenia: 5 FC
• GIT upset: All
• Over all toxicity: highest for AMB lowest for
fluconazole, itraconazole
Editor's Notes
Name polyene is derived from highly double bonded structure
amphotericin B combines avidly with lipids (ergosterol) along the double bond-rich side of its structure and associates with water molecules along the hydroxyl-rich side. This amphipathic characteristic facilitates pore formation by multiple amphotericin molecules, with the lipophilic portions around the outside of the pore and the hydrophilic regions lining the inside. The pore allows the leakage of intracellular ions and macromolecules, eventually leading to cell death. Some binding to human membrane sterols does occur, probably accounting for the drug's prominent toxicity.
Dermatophytes are inhibited in vitro but conc of AMB attained inskin are low and ineffective
Bile salt –doc60% metabolized in liver, excretion occurs slowly in both urine and bile
Started at 0.3 mg/kg – 0.7 mg/kg , 1 mg test dose injected over 20 min to see acute reaction
Owing to its broad spectrum of activity and fungicidal action, amphotericin B remains a useful agent for nearly all life-threatening mycotic infections, although newer less toxic agents have largely replaced amphotericin B for most conditions. It is often used as the initial induction regimen in order to rapidly reduce fungal burden and is then replaced by one of the newer azole drugs (described below) for chronic therapy or prevention of relapse. Such induction therapy is especially important for immunosuppressed patients and those with severe fungal pneumonia, severe cryptococcal meningitis, or disseminated infections with one of the endemic mycoses such as histoplasmosis or coccidioidomycosis. Once a clinical response has been elicited, these patients then often continue maintenance therapy with an azole; therapy may be lifelong in patients at high risk for disease relapse. For treatment of systemic fungal disease, amphotericin B is given by slow intravenous infusion at a dosage of 0.5–1 mg/kg/d. It is usually continued to a defined total dose (eg, 1–2 g), rather than a defined time span, as used with other antimicrobial drugs.
ameliorated by slowing the infusion rate or decreasing the daily dose. Premedication with antipyretics, antihistamines, meperidine, or corticosteroids can be helpful. When starting therapy, many clinicians administer a test dose of 1 mg intravenously to gauge the severity of the reaction. This can serve as a guide to an initial dosing regimen and premedication strategy.
Used in superficialcandidiasis,
Torula, chromoblastomyces, candida some strains
Available as Cream, gel, spray, lotion, pessary ,. ( pedis, cruris, corporis, versicolor)
Most toxic among azoles so not used so much triazolespreferedAcidic environment favours absorption so orange juice increases absorption and proton pump inhibitors decrease absorption. But saturation of metabolism occurs shortly which prolongs the its half life and permits once daily dosing , since small amount of drug appears in urine it is not suitable for
Not used in fungal meningitis
Much less toxic than AMB but more side effects than fluconazole, itraconazoleNausea etc can be minimized by taking with food
Proton pump inhibitors : decrease absorption Rifampicin, phenytoin increase metabolism With sulfonylureas can cause hypoglycemia Nephrotoxicity can occur with cyclosporine H2 receptor blockers ↑ Srconc of cisapride, terfenadine, astemizole, quinidinePhenytoin toxicity Sulfonylureas: hypoglycemiaCyclosporine: nephrotoxicityWarfarin: bleeding Rifampicin, phenytoin ↑ metabolism of ketoconazoleShould not combine with AMB
200 mg OD Also tried in dermal leshmaniasis
Oral candidiasis : fluconazole 200 mg on first day then 100 mg daily for atleast 2 weeksCryptococcosis: 400 mg daily 8 weeks after stabilization with amb , after 8 weeks dose is reduced to 200 mg for life aids related only Coccodiodal meningitis: drug of choice Fluconazole has activity against histoplasma, blasto, sporotrich , ring worm but efficacy less Nor against aspergillusAll azoles not against mucormycosis. Children doses = 3-6 mg/kg
Capsule form of drug better absorbed in fed state , invasive aspergillosis outside the CNSIN treating deep mycosis two 100 mg capsules given twice daily with food , divided doses increase the AUC WHY PULSE THERAPY: retention of active drug in nail keratin . Daily therapy prefered for recurring infection. Terbinbafine 250 mg OD better in onychomycosis than itraconazole
effective against candida & aspergillosis
Not effective in hyperkeratinized lesions like tineapedis , tineacapitis , tineaunginum as poor penetration , symptomatic relief occurs early with tolnaftate but if discontinued before fungal bearing tissue is shed relapses occur